FMT
FOLD

First Mercantile Trust’s Amicus Therapeutics FOLD Stock Holding History

First Mercantile Trust’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,596
Closed -$198K – 860
2020
Q4 		$198K Sell
8,596
-1,854
-18% -$37.9K 0.02% 426
2020
Q3 		$221K Buy
10,450
+262
+3% +$3.82K 0.03% 378
2020
Q2 		$154K Buy
+10,188
New +$124K 0.02% 504

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Mercantile Trust's FOLD Position: Q1 2021 in Review

First Mercantile Trust sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 8,596 shares — an estimated $198K sold.

First Mercantile Trust first reported a position in FOLD in Q2 2020 and held it in 3 quarters. The position peaked at $221K in Q3 2020. 259 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • First Mercantile Trust reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • First Mercantile Trust sold 8,596 Amicus Therapeutics shares in Q1 2021, an estimated $198K.
  • First Mercantile Trust first reported a position in Amicus Therapeutics in Q2 2020 and held it in 3 quarters.
  • First Mercantile Trust's Amicus Therapeutics position peaked at $221K in Q3 2020.
  • 259 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on First Mercantile Trust's 13F filing for Q1 2021, filed 14 May 2021.